4-Chloro-5-fluoro-6-methyl-2-phenylpyrimidine
CAS No.:
1000931-50-9
M. Wt:
222.6499939
M. Fa:
-
InChI Key:
APDNYMRZTXQKOT-UHFFFAOYSA-N
Names and Identifiers of 1000931-50-9
CAS Number |
1000931-50-9 |
|---|---|
MDL Number |
MFCD09863460 |
IUPAC Name |
4-chloro-5-fluoro-6-methyl-2-phenylpyrimidine |
InChI |
InChI=1S/C11H8ClFN2/c1-7-9(13)10(12)15-11(14-7)8-5-3-2-4-6-8/h2-6H,1H3 |
InChIKey |
APDNYMRZTXQKOT-UHFFFAOYSA-N |
Canonical SMILES |
CC1=C(C(=NC(=N1)C2=CC=CC=C2)Cl)F |
UNSPSC Code |
12352100 |
Physical and chemical properties of 1000931-50-9
H Bond Acceptors |
2 |
|---|---|
H Bond Donors |
0 |
LogP |
3.60334875233333 |
Molecular Weight |
222.6499939 |
Safety Information of 1000931-50-9
Applications of 1000931-50-9
4-Chloro-5-fluoro-6-methyl-2-phenylpyrimidine has several applications:
- Pharmaceutical Development: Its structural characteristics make it a candidate for drug development, particularly in creating new antiviral or anticancer agents.
- Agrochemicals: The compound may also find use in agricultural chemicals due to its biological activity against pests and diseases
Interaction Studies of 1000931-50-9
Studies on 4-chloro-5-fluoro-6-methyl-2-phenylpyrimidine's interactions with biological systems are crucial for understanding its efficacy and safety profile. Interaction studies often focus on:
- Protein Binding: Evaluating how well the compound binds to target proteins can provide insights into its therapeutic potential.
- Metabolic Stability: Investigating how metabolic enzymes interact with this compound helps determine its longevity and effectiveness within biological systems
Biological Activity of 1000931-50-9
Research indicates that compounds similar to 4-chloro-5-fluoro-6-methyl-2-phenylpyrimidine exhibit significant biological activity, particularly in the realm of pharmaceuticals. Pyrimidine derivatives are often explored for their potential as antiviral, anticancer, and anti-inflammatory agents. The presence of fluorine is known to enhance biological activity by improving the pharmacokinetic properties of drug candidates